Risk assessment after combination therapy in patients with CHD-PAH and Eisenmenger Syndrome in a low-middle income country - Vienna 2024

Pathophysiology and risk assessment in pulmonary arterial hypertension

Chair(s): St?phanie Saxer, Benjamin Egenlauf

Session type: Poster session

Risk assessment after combination therapy in patients with CHD-PAH and Eisenmenger Syndrome in a low-middle income country

Arturo Cortes-Telles

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Evaluating the socioeconomic burden of pulmonary arterial hypertension on employment and workplace productivity: A Canadian, cross-sectional study

Brandon Budhram

Poster

Abstract

Sex-specific differences in echocardiographic parameters of risk stratification in pulmonary arterial hypertension

Ekkehard Gr?nig

Poster

Abstract

Heart rate variability in patients with pulmonary vascular disease living permanently at high altitude relocated to low altitude

Jo?l Julien Herzig

Poster

Abstract

Nocturnal oxygen desaturation in precapillary pulmonary hypertension

Oksana Kalashnykova

Poster

Abstract

Comparing the PAH patients according to their DLCO: results from a Greek PH center.

Effrosini Dima

Poster

Abstract

Have clinical characteristics of patients with Pulmonary Arterial Hypertension changed over the years?

B?rbara Gracia Hern?ndez

Poster

Abstract

Evaluating the burden of pulmonary arterial hypertension from patient reported changes in work patterns: Results from a Canadian patient survey

Brandon Budhram

Poster

Abstract

Risk assessment after combination therapy in patients with CHD-PAH and Eisenmenger Syndrome in a low-middle income country

Arturo Cortes-telles

Poster

Abstract

The role of gas transfer on responses to exercise training in patients with pulmonary hypertension

Ciara Mccormack

Poster

Abstract

SSc-PAH patients are at risk of disease progression in contemporary clinical practice

Hilde Jenssen Bj?rkekj

Poster

Abstract

The spectrum of systemic sclerosis-associated pulmonary hypertension (SSc-PH): insights from the ASPIRE registry

Howard Smith

Poster

Abstract

Evolution of the incidence of pulmonary arterial hypertension (PAH) in patients with HIV infection over the past 15 years.

Elise Puel

Poster

Abstract

Constant work-rate cycling time and arterial blood gases in lowlanders with pulmonary arterial and chronic thromboembolic pulmonary hypertension on the second day at 2500m a randomized cross-over study

Simon Raphael Schneider

Poster

Abstract

The UK National Cohort Study of Idiopathic and Heritable Pulmonary Arterial Hypertension ten years on: an Overview and its Future.

Eckart De Bie

Poster

Abstract

The utility and safety of one-minute sit-to-stand test in pulmonary hypertension: a prospective study

Kenichiro Takeda

Poster

Abstract

Association between right heart size and right ventricular output reserve in patients with pulmonary arterial hypertension

Benjamin Egenlauf

Poster

Abstract

Characteristics and outcomes of gemcitabine-associated pulmonary hypertension

Pierre Mouillot

Poster

Abstract

The optimal cut-off value for the one-minute sit-to-stand test to determine functional impairment in patients with pulmonary hypertension

Christina Kronberger

Poster

Abstract

The Pulmonary Hypertension Global Patient Survey (PH GPS): an overview and results

Joseph Newman

Poster

Abstract

Prognostic value of follow-up cardiopulmonary exercise testing in pulmonary arterial hypertension

Andrea Baccelli

Poster

Abstract

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}